BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27233608)

  • 1. A new glycotoxins inhibitor attenuates insulin resistance in liver and fat cells.
    Afridi SK; Aftab MF; Murtaza M; Ghaffar S; Karim A; Mughal UR; Khan KM; Waraich RS
    Biochem Biophys Res Commun; 2016 Aug; 476(4):188-195. PubMed ID: 27233608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bis-Schiff base of isatin improves methylglyoxal mediated insulin resistance in skeletal muscle cells.
    Aftab MF; Afridi SK; Ghaffar S; Murtaza M; Khan M; Karim A; Khan KM; Waraich RS
    Arch Pharm Res; 2015 Oct; ():. PubMed ID: 26519157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new indanedione derivative alleviates symptoms of diabetes by modulating RAGE-NF-kappaB pathway in db/db mice.
    Khan G; Aftab MF; Bano B; Khan KM; Murtaza M; Siddiqui S; Rehman MH; Waraich RS
    Biochem Biophys Res Commun; 2018 Jul; 501(4):863-870. PubMed ID: 29778537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New isatin derivative inhibits neurodegeneration by restoring insulin signaling in brain.
    Aftab MF; Afridi SK; Mughal UR; Karim A; Haleem DJ; Kabir N; Khan KM; Hafizur RM; Waraich RS
    J Chem Neuroanat; 2017 Apr; 81():1-9. PubMed ID: 28093241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation.
    Nov O; Kohl A; Lewis EC; Bashan N; Dvir I; Ben-Shlomo S; Fishman S; Wueest S; Konrad D; Rudich A
    Endocrinology; 2010 Sep; 151(9):4247-56. PubMed ID: 20660063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
    Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
    World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Truong CS; Seo E; Jun HS
    Oxid Med Cell Longev; 2019; 2019():4310319. PubMed ID: 31976027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes.
    Unoki H; Bujo H; Yamagishi S; Takeuchi M; Imaizumi T; Saito Y
    Diabetes Res Clin Pract; 2007 May; 76(2):236-44. PubMed ID: 17097186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigment epithelium-derived factor (PEDF) ameliorates advanced glycation end product (AGE)-induced hepatic insulin resistance in vitro by suppressing Rac-1 activation.
    Yoshida T; Yamagishi S; Nakamura K; Matsui T; Imaizumi T; Takeuchi M; Koga H; Ueno T; Sata M
    Horm Metab Res; 2008 Sep; 40(9):620-5. PubMed ID: 18792873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E.
    Fiory F; Lombardi A; Miele C; Giudicelli J; Beguinot F; Van Obberghen E
    Diabetologia; 2011 Nov; 54(11):2941-52. PubMed ID: 21861178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytes.
    Fukuoka H; Iida K; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi M; Okimura Y; Kaji H; Chihara K; Takahashi Y
    Growth Horm IGF Res; 2010 Jun; 20(3):212-9. PubMed ID: 20185348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes.
    Ma SB; Zhang R; Miao S; Gao B; Lu Y; Hui S; Li L; Shi XP; Wen AD
    Mol Med Rep; 2017 Jun; 15(6):3803-3809. PubMed ID: 28393248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
    Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J
    Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cδ but not PKCα is involved in insulin-induced glucose metabolism in hepatocytes.
    Brutman-Barazani T; Horovitz-Fried M; Aga-Mizrachi S; Brand C; Brodie C; Rosa J; Sampson SR
    J Cell Biochem; 2012 Jun; 113(6):2064-76. PubMed ID: 22271577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ER stress in adipocytes inhibits insulin signaling, represses lipolysis, and alters the secretion of adipokines without inhibiting glucose transport.
    Xu L; Spinas GA; Niessen M
    Horm Metab Res; 2010 Aug; 42(9):643-51. PubMed ID: 20560104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
    Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.
    Jager J; Grémeaux T; Cormont M; Le Marchand-Brustel Y; Tanti JF
    Endocrinology; 2007 Jan; 148(1):241-51. PubMed ID: 17038556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of LYRM1 rescues insulin resistance and mitochondrial dysfunction induced by FCCP in 3T3-L1 adipocytes.
    Zhang M; Qin ZY; Dai YM; Wang YM; Zhu GZ; Zhao YP; Ji CB; Zhu JG; Shi CM; Qiu J; Cao XG; Guo XR
    Cell Biochem Biophys; 2014 Sep; 70(1):667-75. PubMed ID: 24771405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.